Serveur d'exploration Tocilizumab - Merge (PascalFrancis)

Index « FA11s1.i » - entrée « NISHIMOTO (Norihiro) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
NISHIMOTO (N.) < NISHIMOTO (Norihiro) < NISHIMURA (Takashi)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000001 (2005) Norihiro NishimotoClinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan
000006 (2007) Naoko Yoshio-Hoshino ; Yasuo Adachi ; Chieko Aoki ; Alexander Pereboev ; David T. Curiel ; Norihiro NishimotoEstablishment of a new lnterleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor
000010 (2007) Norihiro Nishimoto ; Jun Hashimoto ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Norikazu Murata ; Désirée Van Der Heijde ; Tadamitsu KishimotoStudy of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAL) : evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
000014 (2008) Tim Bongartz ; Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis : a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Commentary
000017 (2008) Norihiro Nishimoto ; Hideko Nakahara ; Naoko Yoshio-Hoshino ; Toru MimaSuccessful Treatment of a Patient With Takayasu Arteritis Using a Humanized Anti-Interleukin-6 Receptor Antibody
000018 (2008) Yasuo Adachi ; Naoko Yoshio-Hoshino ; Norihiro NishimotoThe Blockade of IL-6 Signaling in Rational Drug Design
000021 (2008) Yasuo Adachi ; Naoko Yoshio-Hoshino ; Norihiro NishimotoGene therapy for Multiple Myeloma
000028 (2008) Norihiro Nishimoto ; Kimio Terao ; Toru Mima ; Hideko Nakahara ; Nobuhiro Takagi ; Takahiro KakehiMechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
000065 (2010) Yasuo Adachi ; Naoko Yoshio-Hoshino ; Chieko Aoki ; Norihiro NishimotoVEGF Targeting in Mesotheliomas Using an Interleukin-6 Signal Inhibitor Based on Adenovirus Gene Delivery
000087 (2011) Isao Tawara ; Motoko Koyama ; CHEN LIU ; Tomomi Toubai ; Dafydd Thomas ; Rebecca Evers ; Peter Chockley ; Evelyn Nieves ; YAPING SUN ; Kathleen P. Lowler ; Chelsea Malter ; Norihiro Nishimoto ; Geoffrey R. Hill ; Pavan ReddyInterleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
000249 (2014) Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLongterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "NISHIMOTO (Norihiro)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i  \
                -Sk "NISHIMOTO (Norihiro)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PascalFrancis
   |étape=   Merge
   |type=    indexItem
   |index=    FA11s1.i
   |clé=    NISHIMOTO (Norihiro)
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021